CLINICAL_TRIALS
trial_result
· 2020-02-24
Clinical Trial Update: Pharmacological Activation of HMN for OSA [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial assessing pharmacological activation of HMN for obstructive sleep apnea has completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Obstructive Sleep Apnea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-24